Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- A3817 SildenafilTarget: Phosphodiesterases (PDEs)Summary: PDE5 inhibitor, selective
- B1386 MilrinoneTarget: Phosphodiesterases (PDEs)Summary: PDE-3 inhibitor
- B3439 UdenafilTarget: Phosphodiesterases (PDEs)Summary: PDE5 inhibitor
- B6304 Etazolate hydrochloride2 CitationTarget: Phosphodiesterases (PDEs)Summary: PDE-4 inhibitor and selective GABA-A receptor modulator
- B6988 BRL 50481Target: Phosphodiesterases (PDEs)Summary: PDE7 inhibitor,potent and selective
- B2276 VinpocetineTarget: Phosphodiesterases (PDEs)Summary: PDE inhibitor